Patients with ANCA-associated vasculitis receiving low glucocorticoid doses as per the PEXIVAS trial faced an increased risk ...

Approved therapies focus primarily on disease symptoms and can involve significant side effects. Anti-neutrophilic cytoplasmic autoantibody (ANCA) vasculitis is an autoimmune disease characterized by ...

Detailed price information for Sana Biotechnology Inc (SANA-Q) from The Globe and Mail including charting and trades.

Autoimmune diseases occur due to a dysregulation within the immune system, leading to an aberrant assault on the organism’s own tissues. The pathogenesis of these conditions is multifactorial, ...

The complex interaction between the immune system and autoinflammatory disorders highlights the centrality of autoimmune mechanisms in the pathogenesis of autoinflammatory diseases. With the ...

Other systemic immune-mediated diseases that ... hepatitis C-associated vasculitis, undifferentiated connective tissue disease, polymyalgia rheumatica, pyoderma gangrenosum, sarcoidosis and ...

Researchers have developed a novel T-cell therapy with the potential to target B-cell-driven diseases, including autoimmune disorders such as antineutrophil cytoplasmic antibody (ANCA)-associated ...

The following is a summary of “Nodular vasculitis – Retrospective study of an uncommon disease in a non-tuberculosis endemic country with focus on treatment modalities and efficacy,” published in the ...

The Canadian Chronic Disease Indicators (CCDI) provide information on chronic diseases, their determinants, and their risk and protective factors in Canada. Using an intuitive Data Tool, pan-Canadian ...

People who have the condition suffer from a build-up of immune cells that produce the IgG4 antibody in certain organs. The disease can affect any organ and frequently involves multiple organs ...

Systemic vasculitis is a group of rare diseases that share an essential characteristic: inflammation of blood vessel walls. This injury occurs during the disease course, but specific features vary for ...